Clinical Trial Update: Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia

View source ↗

Summary

A clinical trial update assessing the use of imipenem with sulbactam to treat bacteremia caused by imipenem-resistant Acinetobacter baumannii.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Bacteremia

Drugs mentioned

• Imipenem
• Sulbactam (sulbactam)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Acinetobacter Bacteraemia | Status: UNKNOWN